Prolongation of primate cardiac allograft survival by treatment with anti-CD40 ligand (CD154) antibody

Transplantation

Volumn 68, Issue 11, 1999, Pages 1800-1805

  Pierson III, Richard N ^a   Chang, Andrew C ^a   Blum, Matthew G ^a   Blair, Kelly S A ^a   Scorr, Margie A ^a   Atkinson, James B ^a   Collins, Brendan J ^a   Zhang, Jian Ping ^a   Thomas, David W ^b,c   Burkly, Linda C ^b   Miller, Geraldine G ^d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b BIOGEN   (United States)

^c Tanox Biosystems Inc   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD154 ANTIBODY; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; GRAFT SURVIVAL; HEART TRANSPLANTATION; MONKEY; NONHUMAN; PRIORITY JOURNAL; XENOTRANSPLANTATION;

EID: 0033573076     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199912150-00026     Document Type: Article

References (12)

1. Armitage RJ, Fanslow WC, Strockbine L, et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357(6373): 80.
2. + T cells that induces contact-dependent B cell differentiation (help). J Exp Med 1992; 175(4): 1091.
3. Noelle RJ, Ledbetter JA, Aruffo A. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol Today 1992; 13(11): 431.
4. Kirk AD, Harlan DM, Armstrong NN, et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 1997; 94(16): 8789.
5. Kirk AD, Burkly LC, Batty DS, et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nature Med 1999; 5(6): 686.
6. Kenyon NS, Chatzipetrou M, Masetti M, et al. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD 154. Proc Natl Acad Sci USA 1999; 96: 8132.
7. Klima U, Guerrero JL, Levine RA, Vlahakes GJ. A new, biventricular working heterotopic heart transplant model: anatomic and physiologic considerations. Transplantation 1997; 64(2): 215.
8. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990; 9(6): 587.
9. + human T cells. J Immunol 1996; 157: 4771.
10. Gobburu JV, Tenhoor C, Rogge MC, et al. Pharmacokinetics/dynamics of 5c8, a monoclonal antibody to CD154 (CD40 ligand) suppression of an immune response in monkeys. J Pharmacol Exp Ther 1998; 286(2): 925.
11. Chang AC, Blum MG, Blair KSA, et al. Modulation of interleukin-12 gene expression in primate cardiac allografts during anti-CD40 ligand monoclonal antibody treatment. Surg Forum 1998; 49: 382.
12. Larsen CP, Alexander DZ, Hollenbaugh D, et al. CD40-gp39 interactions play a critical role during allograft rejection: suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 1996; 61(1): 4.